Aleph

Aleph is a prominent early-stage venture capital firm based in Tel Aviv, Israel, established in 2013 by co-founders Michael Eisenberg and Eden Shochat. Their core mission is to partner with Israeli entrepreneurs who are building large, impactful global companies and brands. The firm primarily focuses on Seed and Series A investments, aiming to provide significant value beyond just capital, positioning themselves as active partners in their portfolio companies' growth.

Aleph distinguishes itself through a hands-on, value-add approach, emphasizing deep engagement with its portfolio companies. They offer strategic guidance, operational support, and access to their extensive network, particularly in areas like talent acquisition, business development, and market expansion. The firm actively seeks out "bold, global-minded" entrepreneurs with ambitious visions, fostering a collaborative environment to help them scale internationally. Their investment thesis centers on identifying disruptive technologies and business models emerging from the vibrant Israeli tech ecosystem.

Aleph has successfully raised four funds, accumulating approximately $820 million in total assets under management. Their most recent fund, Aleph IV, closed in 2022 with $300 million, reflecting continued investor confidence in their strategy and the Israeli market. Typically, Aleph's initial investment checks range from $1 million to $8 million, primarily targeting Series A rounds, though they also participate in select seed opportunities. Their portfolio includes several high-profile companies that have achieved global recognition, such as Lemonade, Honeybook, and Healthy.io, showcasing their ability to identify and nurture future industry leaders.